login
login

Europe Daily Bulletin No. 12721

19 May 2021
Contents Publication in full By article 20 / 37
EU RESPONSE TO COVID-19 / Trade
G20 expected to vote against patent waiver for Covid-19 vaccines
Brussels, 18/05/2021 (Agence Europe)

At the global health summit on 21 May, G20 leaders are expected to vote against waiving patents on Covid-19 vaccines, according to draft conclusions seen by Reuters. Instead, the G20 countries will reportedly advocate voluntary sharing of intellectual property rights by pharmaceutical companies. 

The debate has been raging in the international community since October 2020, when South Africa and India proposed a patent waiver for Covid-19 vaccines. Discussions are still ongoing at the WTO...

Contents

EXTERNAL ACTION
ECONOMY - FINANCE - BUSINESS
EUROPEAN PARLIAMENT PLENARY
EU RESPONSE TO COVID-19
CULTURE
SECTORAL POLICIES
INSTITUTIONAL
COURT OF JUSTICE OF THE EU
NEWS BRIEFS